BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

FemHealth Focus

Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...

December 23, 2025 | News

Alphamab Oncology’s JSKN003 Gains FDA Breakthrough Therapy Designation For Platinum Resistant Ovarian Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the...

December 23, 2025 | News

PT Fapon Bioindustries Indonesia And Bio Farma Sign Strategic IVD Manufacturing Partnership

PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred...

December 09, 2025 | News

Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs Lunit (KRX:328130), ...

December 09, 2025 | News

Sapu Nano Unveils Biomarker Signature Predicting Sensitivity to Intravenous Sapu003

Sapu Nano announced new biomarker data identifying a molecular signature that predicts sensitivity to Sapu003, the company’s intravenous D...

December 08, 2025 | News

Ikonopedia Expands Breast Imaging Platform with Contrast-Enhanced Mammography

-- Ikonopedia, a leader in breast imaging reporting and tracking systems, today announced the addition of Contrast-Enhanced Mammography (CEM) to its i...

December 01, 2025 | News

Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs

An international survey, spanning Australia, France, Japan, Poland and the UK, has found that many employees experiencing fertility challenges lack support...

November 27, 2025 | Report

Accord BioPharma Gains FDA Approval for Two Denosumab Biosimilars to Expand Access to Osteoporosis and Cancer Related Bone Care

Products will treat osteoporosis and skeletal-related events from certain types of bone cancer, expanding the company's biosimilar portfolio Accord BioPha...

November 21, 2025 | News

Guided Therapeutics Secures New LuViva Supply Agreement to Expand Cervical Cancer Screening Reach in China

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuansh...

November 21, 2025 | News

Kazia Reports Initial Immune Complete Response in Stage IV Triple Negative Breast Cancer Under Expanded Access Combination Regimen

Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, announced that a patient with stage IV triple-negative breast canc...

November 20, 2025 | News

Akeso Secures Fourth Breakthrough Therapy Designation for Ivonescimab in Combination Therapy for Triple-Negative Breast Cancer

Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for fi...

November 04, 2025 | News